ACTIVE INGREDIENTS: Each 5 mL (teaspoonful) contains:
Phenylephrine Hydrochloride.......................... 7.5 mg
Guaifenesin....................................................... 100 mg
Phenylephrine hydrochloride is an adrenergic. Guaifenesin is an expectorant.
Crantex (Phenylephrine/Guaifenesin) is indicated for the following:
For temporary relief of symptoms associated with the common cold, influenza, and bronchitis.
Clinical Trials Related to Crantex (Phenylephrine / Guaifenesin)
Muscle-Related Side Effects of Statins: Functional Impact, Mechanisms, and Potential Relief With Vitamin D Supplementation [Recruiting]
This proposal will explore muscle function (strength and endurance) in men and women
suffering from statin-induced muscle symptoms. The mechanisms responsible for these muscle
symptoms will be explored. Also, the investigators will assess the potential usefulness of
vitamin D supplementation in a randomized control trial.
Preventing Frequent Sinus Infections in HIV-Infected Patients [Withdrawn]
To evaluate the additional effectiveness of an anti-inflammatory nasal spray (
beclomethasone dipropionate ) and a broad spectrum antibiotic ( cefuroxime axetil ) over
decongestant ( Deconsal II ) alone, when these agents are given individually or in
combination for the prevention of recurrent paranasal sinus infection in patients with HIV
infection. To compare the clinical utility of paranasal sinus radiographs with computed
tomograms (CTs) in the evaluation and management of HIV-infected patients with recurrent
paranasal sinus infection. To determine relevant prognostic factors and the microbiologic
etiology of maxillary sinusitis in this patient population.
Sinusitis is common among HIV-infected patients and is likely to be recurrent or refractory
to traditional therapy, particularly in patients with advanced immunosuppression. An
intervention aimed at prevention of recurrent sinus disease in HIV-infected patients appears
to be warranted.
Control of Periodontal Infections [Completed]
The purpose of this study is to test combined effects of scaling and root planing with
periodontal surgery, systemically administered amoxicillin and metronidazole, and/or local
tetracycline on pocket depth reduction and attachment level "gain" in patients with chronic
Page last updated: 2009-10-09